292 related articles for article (PubMed ID: 27022417)
21. In Vivo 3-Dimensional Radiopharmaceutical-Excited Fluorescence Tomography.
Hu Z; Zhao M; Qu Y; Zhang X; Zhang M; Liu M; Guo H; Zhang Z; Wang J; Yang W; Tian J
J Nucl Med; 2017 Jan; 58(1):169-174. PubMed ID: 27660137
[TBL] [Abstract][Full Text] [Related]
22. Radiopharmaceutical and Eu
Shi X; Cao C; Zhang Z; Tian J; Hu Z
J Nanobiotechnology; 2021 Jul; 19(1):212. PubMed ID: 34271928
[TBL] [Abstract][Full Text] [Related]
23. Comparison of two new angiogenesis PET tracers 68Ga-NODAGA-E[c(RGDyK)]2 and (64)Cu-NODAGA-E[c(RGDyK)]2; in vivo imaging studies in human xenograft tumors.
Oxboel J; Brandt-Larsen M; Schjoeth-Eskesen C; Myschetzky R; El-Ali HH; Madsen J; Kjaer A
Nucl Med Biol; 2014 Mar; 41(3):259-67. PubMed ID: 24417983
[TBL] [Abstract][Full Text] [Related]
24. Enantiopure bifunctional chelators for copper radiopharmaceuticals--does chirality matter in radiotracer design?
Singh AN; Dakanali M; Hao G; Ramezani S; Kumar A; Sun X
Eur J Med Chem; 2014 Jun; 80():308-15. PubMed ID: 24793881
[TBL] [Abstract][Full Text] [Related]
25. Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen ML; Oyen WJ; Dijkgraaf I; Massuger LF; Frielink C; Edwards DS; Rajopadhye M; Boonstra H; Corstens FH; Boerman OC
Cancer Res; 2002 Nov; 62(21):6146-51. PubMed ID: 12414640
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of [
Cortez A; Josefsson A; McCarty G; Shtekler AE; Rao A; Austin Z; Nedrow JR
Nucl Med Biol; 2020; 88-89():62-72. PubMed ID: 32799049
[TBL] [Abstract][Full Text] [Related]
27. Radiogallium Complex-Conjugated Bifunctional Peptides for Detecting Primary Cancer and Bone Metastases Simultaneously.
Ogawa K; Yu J; Ishizaki A; Yokokawa M; Kitamura M; Kitamura Y; Shiba K; Odani A
Bioconjug Chem; 2015 Aug; 26(8):1561-70. PubMed ID: 26087328
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
Liu S; Hsieh WY; Jiang Y; Kim YS; Sreerama SG; Chen X; Jia B; Wang F
Bioconjug Chem; 2007; 18(2):438-46. PubMed ID: 17341108
[TBL] [Abstract][Full Text] [Related]
29. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
30. LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.
Woodward J; Kennel SJ; Stuckey A; Osborne D; Wall J; Rondinone AJ; Standaert RF; Mirzadeh S
Bioconjug Chem; 2011 Apr; 22(4):766-76. PubMed ID: 21434681
[TBL] [Abstract][Full Text] [Related]
31. Intrinsically radioactive [64Cu]CuInS/ZnS quantum dots for PET and optical imaging: improved radiochemical stability and controllable Cerenkov luminescence.
Guo W; Sun X; Jacobson O; Yan X; Min K; Srivatsan A; Niu G; Kiesewetter DO; Chang J; Chen X
ACS Nano; 2015 Jan; 9(1):488-95. PubMed ID: 25549258
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive visualization and quantification of tumor αVβ3 integrin expression using a novel positron emission tomography probe, 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH; Furukawa T; Galibert M; Boturyn D; Coll JL; Fukumura T; Saga T; Dumy P; Fujibayashi Y
Nucl Med Biol; 2011 May; 38(4):529-40. PubMed ID: 21531290
[TBL] [Abstract][Full Text] [Related]
33. In vivo nanoparticle-mediated radiopharmaceutical-excited fluorescence molecular imaging.
Hu Z; Qu Y; Wang K; Zhang X; Zha J; Song T; Bao C; Liu H; Wang Z; Wang J; Liu Z; Liu H; Tian J
Nat Commun; 2015 Jun; 6():7560. PubMed ID: 26123615
[TBL] [Abstract][Full Text] [Related]
34. alpha(v)beta(3) Integrin-targeting radionuclide therapy and imaging with monomeric RGD peptide.
Yoshimoto M; Ogawa K; Washiyama K; Shikano N; Mori H; Amano R; Kawai K
Int J Cancer; 2008 Aug; 123(3):709-15. PubMed ID: 18498129
[TBL] [Abstract][Full Text] [Related]
35. [⁶⁸Ga]NS₃-RGD and [⁶⁸Ga] Oxo-DO3A-RGD for imaging α(v)β₃ integrin expression: synthesis, evaluation, and comparison.
Knetsch PA; Petrik M; Rangger C; Seidel G; Pietzsch HJ; Virgolini I; Decristoforo C; Haubner R
Nucl Med Biol; 2013 Jan; 40(1):65-72. PubMed ID: 23102540
[TBL] [Abstract][Full Text] [Related]
36. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
37. Comparison of biological properties of (111)In-labeled dimeric cyclic RGD peptides.
Zheng Y; Ji S; Tomaselli E; Yang Y; Liu S
Nucl Med Biol; 2015 Feb; 42(2):137-45. PubMed ID: 25459111
[TBL] [Abstract][Full Text] [Related]
38. Hybrid Light Imaging Using Cerenkov Luminescence and Liquid Scintillation for Preclinical Optical Imaging In Vivo.
Shimamoto M; Gotoh K; Hasegawa K; Kojima A
Mol Imaging Biol; 2016 Aug; 18(4):500-9. PubMed ID: 26819217
[TBL] [Abstract][Full Text] [Related]
39. An improved method of 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK).
Lee YS; Jeong JM; Kim HW; Chang YS; Kim YJ; Hong MK; Rai GB; Chi DY; Kang WJ; Kang JH; Lee DS; Chung JK; Lee MC; Suh YG
Nucl Med Biol; 2006 Jul; 33(5):677-83. PubMed ID: 16843843
[TBL] [Abstract][Full Text] [Related]
40. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis.
Chen X; Park R; Shahinian AH; Tohme M; Khankaldyyan V; Bozorgzadeh MH; Bading JR; Moats R; Laug WE; Conti PS
Nucl Med Biol; 2004 Feb; 31(2):179-89. PubMed ID: 15013483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
